Our privacy policy describes how Fidessa uses cookies on our website. If you continue using our website, you are consenting to our use of cookies. OK

Symphony strikes a chord

I have been following the Symphony story with interest and the recent news that Google’s parent company, Alphabet, is looking to invest certainly got my attention. Is this the sound of the mighty Google taking its first lumbering steps into the world of capital markets, or just another of the many investments that Google makes? More importantly, what does this do to help Symphony? Well cash is always nice, but the real challenge for Symphony is creating the tipping point where the mass market abandons Bloomberg IM and moves to its product instead.

The key to this is the buy-side, as the sell-side is compelled to adopt whatever chat application their customers use. This isn’t so they can keep in touch or chat about last night’s game, but because this is where orders or sales enquiries can come from. So it’s simple then, if the majority of buy-sides still use Bloomberg nothing much will change. Most likely is that brokers will be forced to run two chat environments which is hardly ideal. On the other hand, if Symphony can gain some regulatory advantage over Bloomberg, or develop some killer messaging application that Bloomberg doesn’t have, then things may start to change very quickly.

One way for Symphony to achieve this is by engaging with other technology vendors that have their own buy- and sell-side communities. So, thanks to Google, they should be able to buy me a nice lunch…

Leave a comment

Copyright © 2017 Fidessa group plc. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Fragulator® is a registered trademark of Fidessa group plc.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.